To the Editor:— The editorial, What's in a Name?, which appeared inThe Journal, Aug. 6, page 1580, recommending wider use of generic names, contains a number of interesting facts but omits mention of some rather important considerations. The trade name of a drug represents a very substantial contribution of time and effort given to chemical, pharmacological, and clinical research. The owner of that trade name, in his own self-interest, must protect that investment by rigid quality controls, so that every tablet or teaspoonful will have exactly the same ingredients, the same physical characteristics, and, therefore, the same pharmacological action as every other tablet or teaspoonful. In contrast, many purveyors of drugs under generic names are under no such compulsion, since they sell mainly to those who want something just as good—only cheaper. The physician who purchases an automobile, an air conditioner, a shirt, or even a pack of cigarettes